Work

Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB–IVA carcinoma of the cervix: a Southwest Oncology Group study

Year: 2004

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2004.07.009

Authors: Robert S. Lavey, P.Y. Liu, Benjamin E. Greer, William R. Robinson, Pui C. Chang, Raymond B. Wynn, Marcel E. Conrad, Caroline Jiang, Maurie Markman, David S. Alberts

Institutions: University of Southern California, SWOG Cancer Research Network, Harrington Cancer Center, Tulane University, Louisiana State University, The University of Texas MD Anderson Cancer Center, University of Arizona Cancer Center

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Columbus Community Clinical Oncology Program (Columbus CCOP), UCLA/JCCC--SOUTHWEST ONCOLOGY GROUP, G1794831901, Southwest Oncology Group U10 Member Site, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, SOUTHWEST ONCOLOGY GROUP, G4991842728, SOUTHWEST ONCOLOGY GROUP, Southwest Oncology Group Treatment Grant, SOUTHWEST ONCOLOGY GROUP, Southwest Oncology Group, Gulf Coast MBCCOP, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, SOUTHWEST ONCOLOGY GROUP, University of Colorado Southwest Oncology Group, LSUHSC Minority-Based Community Clinical Oncology Program, SOUTHWEST ONCOLOGY GROUP--COOP GROUP CLINICAL STUDY, G763325562, Kansas City Clincal Oncology Program CCOP, ST Louis-Cape Girardeau CCOP, SOUTHWEST ONCOLOGY GROUP, Southwest Oncology Group/University of California, Davis

OpenAlex ID: W2156671739

FWCI: 5.332

Cites: 36

Cited by: 55

Related to: 10